Global Clinical Trial Imaging Market is expected to reach USD1476.12 Million by 2026 from USDXX Million in 2019 at CAGR of XX% during forecast period.
The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.
To know about the Research Methodology :- Request Free Sample Report
Key factors powering market growth are the raising number of contract research organizations, development in the pharmaceutical & biotechnology industries, and growing in R&D expenditure are the important drivers for the growth of the clinical trial imaging market. However, the high implementation cost of imaging systems is limiting the growth of clinical trial imaging market.
Global clinical trial imaging market is segmented by product & services, imaging modality, end user, and geography. Imaging Modality is segmented by magnetic resonance imaging, computed tomography, positron emission tomography, ultrasound, and others. Computed Tomography segment is expected to register the highest growth in the forecast period. High advantages of CT in screenings for cancer (tumors), injuries, and abnormalities inside the body are expected to drive computed tomography market growth.
Based on Product & Services Market is segmented into software & services. Services sub-segment is estimated to hold the largest market share in the forecast period. The high cost of the imaging equipment, which is leading to increased outsourcing of imaging clinical trial by pharmaceutical, biotechnology, and medical device manufacturers to service providers will result into the increasing share of services segment market.
APAC is going to emerge as one of the higher growth regions during forecast period followed by North America and Europe owing to increasing development in pharmaceutical & biotechnology industries and raising R&D spending in the region will fuel the global clinical trial imaging market in APAC region.
Scope Global Clinical Trial Imaging Market : Inquire before buying
Global Clinical Trial Imaging Market by Product & Services:
Global Clinical Trial Imaging Market by Imaging Modality:
• Magnetic Resonance Imaging (MRI)
• Computed Tomography (CT)
• Positron Emission Tomography (PET)
• Other Imaging Modalities
Global Clinical Trial Imaging Market by End User:
• Pharmaceutical Companies
• Biotechnology Companies
• Medical Device Manufacturers
• Contract Research Organizations
• Academic and Government Research Institutes
• Other End Users (Cosmetics & skin care industries)
Global Clinical Trial Imaging Market by Region:
• North America
• Asia Pacific
• Middle East & Africa
• Latin America.
Key Players analyzed in the global clinical trial imaging market:
• Worldcare Clinical, LLC
• Radiant Sage LLC
• Ixico PLC
• Intrinsic Imaging LLC
• Cardiovascular Imaging Technologies, LLC
• Biotelemetry, Inc.
• Biomedical Systems Corporation
• Icon PLC
• Parexel International Corporation
• Bioclinica, Inc.
• Resonance Health
• Lyscaut Medical Imaging Company
• Quotient Sciences
• Navitas Life Sciences
• Image Core Lab
• ERT Clinical
• Perspectum Diagnostics
• Anagram 4 clinical trials
• Prism Clinical Imaging
Maximize Market Research offers customization of report and scope of the report as per the specific requirement of our client.
For More Information Visit @: https://www.maximizemarketresearch.com/market-report/global-clinical-trial-imaging-market/6603/
This Report Is Submitted By: Maximize Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.